Dr. Dan explains the FDA approval of a new treatment combination for Multiple Myeloma patients. Article from February 2021.
Nadine hasn’t slowed down while fighting metastatic breast cancer and defining what GRYT is.
In 2019, Rachel shared with us her struggles with accepting her Hodgkin’s lymphoma diagnosis.
Non-Hodgkin’s Lymphoma survivor Michele doesn’t let cancer define her, she let’s GRYT do the job.
In January 2021, Dr. Dan explains this new therapy option for relapsed or refractory mantle cell lymphoma patients.
In October 2019, Gryt Health acquired ownership of Vivibot, our mental health, interactive chatbot designed to help cancer survivors learn practical coping skills and hear stories from other survivors after treatment. Here’s the press release making the announcement.
Blues singer and prune enthusiast, Rhayne, didn’t let breast cancer define her. See what “GRYT is” to her.
After surviving neurofibromatosis as a child, Katie was diagnosed with stage IV metastatic breast cancer at age 27, just 2 months matriculating from college. Yet she is still defining what Gryt is.
In February 2021, the FDA approved a new treatment combination for unresectable malignant pleural mesothelioma patients and Gryt Health’s Chief Medical Officer, Dr. Dan breaks it down for us.
When dealing with chronic illness for decades, quality healthcare is a critical thing to have. Alyssa has been living with Crohn’s Disease since 2003 and has had her share of great and horrible experiences. She took some time to share with us what quality healthcare means to her.
